Creation of the Institut Pasteur-UCSF QBI Center of Excellence in Emerging Infectious Diseases Two academic and scientific heavyweights, the Institut Pasteur and UC San Francisco Quantitative Biosciences Institute (UCSF QBI), agree to implement joint actions towards the creation of a center of excellence in emerging infectious diseases with planned operations/locations…..
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform AstriVax will draw on technology developed at the KU Leuven Rega Institute (Belgium) to develop novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various pathogens. Closing on…..
Trend Chart On Innovative Bioindustries - July 2020, 29th FEATURE STORY GSK and CureVac announce strategic mRNA technology collaboration GSK and CureVac announced on July 20th the signing of a strategic collaboration agreement for the research, development, manufacturing and commercialisation of up to five mRNA-based vaccines and monoclonal antibodies targeting…..
